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ABSTRACT
Cigarette Smoke Increases Cardiomyocyte
Ceramide Accumulation and Inhibits
Mitochondrial Respiration
Trevor Stanley Tippetts
Department of Physiology and Developmental Biology, BYU
Master of Science
Cigarette smoking is a common and lethal worldwide habit, with considerable mortality
stemming from its deleterious effects on heart function. While current theories posit altered
blood lipids and fibrinogen metabolism as likely mediators, none have explored the role of the
sphingolipid ceramide in exacerbating heart function with smoke exposure. Ceramide production
is a consequence of cigarette smoke in the lung, and considering ceramide’s harmful effects on
mitochondrial function, we sought to elucidate the role of ceramide in mediating smoke-induced
altered heart mitochondrial respiration.
Lung cells were exposed to cigarette smoke extract and heart cells were exposed to the
lung-cell conditioned medium. Adult male mice were exposed sidestream cigarette smoke for 8
weeks with dietary intervention and ceramide inhibition. Ceramides and heart cell or myocardial
mitochondrial respiration were determined.
Lung cell cultures revealed a robust response to cigarette smoke extract in both
production and secretion of ceramides. Heart cells incubated with lung-cell conditioned medium
revealed a pronounced inhibition of myocardial mitochondrial respiration, though this effect was
mitigated with ceramide inhibition via myriocin. In vivo, heart ceramides increased roughly
600% in adult mice with long-term sidestream cigarette smoke exposure. This resulted in a
significant ceramide-dependent reduction in left myocardial mitochondrial respiration, as heart
mitochondria from the mice exposed to both smoke and myriocin injections respired normally.
These results suggest ceramide to be an important mediator of altered myocardial
mitochondrial function with cigarette smoke exposure. Thus, anti-ceramide therapies might be
considered in the future to protect heart mitochondrial function with smoke exposure.
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CHAPTER 1: Introduction
Cigarette smoke exposure is the leading cause of preventable deaths worldwide (WHO,
2011) and is currently one of the top ten contributors to the worldwide health burden (Deitel,
2003). Currently, there are a number of initiatives underway to reduce the prevalence of
smoking. Despite the best effort of these initiatives, current trends indicate that the number of
smokers will continue to increase worldwide (Ng et al., 2014; SAMHS, 2011). Cigarette smoke
is also a commonly inhaled toxin. Almost half of the U.S. population is regularly exposed to
cigarette smoke (Pirkle, Bernert, Caudill, Sosnoff, & Pechacek, 2006; Pirkle et al., 1996).
Additionally, it is estimated that 20% of young children live with someone who smokes in their
home (CDC, 2010). This alarming trend gives rise to the notion that cigarette smoking and
related diseases will continue to be a world health burden. Exhaustive research is necessary to
discover the full range of co-morbidities associated with cigarette smoking and a potential
therapeutic method of treatment of related.
The Heart
Many of the health risks of smoking are associated with increased risks of chronic
diseases. These diseases include cancer, emphysema, coronary heart disease, including
cardiomyopathy (a deterioration of the heart muscle), and more (CDC, 2008; Lakier, 1992).
Currently, cardiovascular disease is the leading cause of death in the United States (CDC, 2013).
Cardiomyocytes are extremely metabolically active and highly oxidative cells. Because
cardiomyocytes are highly oxidative, cardiomyocytes have a tremendous reliance on
mitochondrial capacity (Lopaschuk & Jaswal, 2010). Altered function of mitochondria can
directly lead to heart failure (Holmgren et al., 2003; Lesnefsky, Moghaddas, Tandler, Kerner, &
Hoppel, 2001; Winter & Buist, 2000), which is a common consequence of cardiomyopathy.
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As stated, the healthy function of mitochondria is essential to cardiomyocytes.
Considering the importance of mitochondria in cardiomyocytes, pathologies and deleterious
conditions that affect proper mitochondrial function in the heart are worth studying. Elucidating
the factors that mediate altered cardiomyocyte mitochondrial physiology and the effects
compounded by cigarette smoke exposure, a potent toxin, is a valuable area of study. Previous
studies have observed that cigarette smoke inhibits mitochondrial respiratory function in
lymphocytes (Miro et al., 1999) and myocardium (Knight-Lozano et al., 2002), but a mechanism
for this inhibition has not been identified.
Ceramide
Ceramide is known as a sphingolipid. Sphingolipids were named after the enigmatic
sphinx (Merrill et al., 1997). The functions of sphingolipids were unknown for a long period of
time and thought to be a purely structural element of the cellular membrane (Simons & Ikonen,
1997). After extensive research, ceramide has been better characterized. Ceramide composed of
sphingosine and a fatty acid and is synthesized from both a de novo pathway and a recycled
pathway. Ceramide is synthesized de novo through an enzymatic cascade. Beginning with the
substrates palmitoyl-CoA and serine, ceramide is produced through the reactions with the
following enzymes: serine palmitoyltransferase (the rate-limiting enzyme in ceramide
production), 3-ketosphingosine reductase, ceramide synthase, and dihydroceramide desaturase
(Brice & Cowart, 2011).
In addition to the de novo pathway, ceramide is can be formed through a recycle
pathway. Through the hydrolysis of sphingomyelin via sphingomyelinase enzymes, ceramide is
formed (Claus, Dorer, Bunck, & Deigner, 2009). Some studies have explored the importance of
the de novo pathway versus the recycle pathway. Gillard et al. showed that the importance of the
2

pathway depends on the cell type. Beyond the cell type, the current cell growth state and need for
mitosis also regulates the reliance on each pathway. It was shown that as a cell grows, there is a
greater need for de novo synthesis (Gillard, Clement, & Marcus, 1998).
As ceramide is studied further, distinct effects of ceramide have become evident.
Ceramide accumulation in tissue was shown to induce apoptosis, programmed cell death
(Haimovitz-Friedman, 1994). Additionally, an inhibition of ceramide production was shown to
attenuate apoptosis (Dbaibo et al., 2001). As the known effects of ceramide continues to grow,
all signs are pointing to the increased accumulation of ceramide leads to numerous pathologies.
These pathologies associated with ceramide accumulation include obesity, metabolic syndrome,
Alzheimer’s disease, and other pathologies (Yuyama, Mitsutake, & Igarashi, 2014).
The accumulation of ceramide may be an important factor in the development of
cardiomyopathy. Ceramide has been shown to induce the release of proteins that induce
apoptosis in the heart.
Cigarette Smoke
Cigarette smoke has been identified as a potent activator of inflammatory pathways in the
lung (Reynolds et al., 2010). This inflammatory response has been shown to cause increased
ceramide biosynthesis (Bikman, 2012; Holland et al., 2011). Ceramides are known to be
important in the disruption of mitochondrial structure and function (Bikman & Summers, 2011;
Gudz, Tserng, & Hoppel, 1997) which may possibly increase the risk of cardiomyopathy (MarinGarcia, Goldenthal, Pierpont, & Ananthakrishnan, 1995). This leads to an intriguing model for
potential ceramide accumulation in the heart. Because the heart is the next major anatomical
structure after the lungs via the pulmonary vein, it is the downstream organ of pulmonary
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ceramide release. The heart may receive a large and unhealthy dose of secreted ceramides from
the lung in response to cigarette smoke exposure.
Diet
Additionally, obesity is a prevalent condition in the United States with approximately
35% of the adult population being obese (Ogden, Carroll, Kit, & Flegal, 2014). Diet and lifestyle
are considered to be major factors in the prevalence of obesity (Wing et al., 2001). The western
diet consists of high-sugar and high-fat content (Turnbaugh, Backhed, Fulton, & Gordon, 2008).
The western diet has been linked to many pathologies. These pathologies include, but are not
limited to; obesity, increased accrual of ceramide in tissues, gut microbiome changes, nonalcoholic fatty liver disease, atherosclerosis and others (Kasumov et al., 2015; Turnbaugh et al.,
2008).
Whether or not cigarette smoking leads to reduced risks of obesity is a controversial
subject. Conflicting studies have found that there may be evidence linking cigarette smoking to a
greater risk of obesity (Chiolero, Faeh, Paccaud, & Cornuz, 2008; Thatcher et al., 2014) Obesity
and an increase in sphingolipids leads to a greater risk for metabolic and cardiovascular disorders
(Borodzicz, Czarzasta, Kuch, & Cudnoch-Jedrzejewska, 2015). With this in mind, a view of how
cigarette smoke exposure and the western diet interact with the heart is worth studying.
Summary of Research
The research performed in our lab has generally focused on ceramide and its wide range
of effects. Specifically, we have previously demonstrated that ceramides are secreted from A549
lung cells are potent producers of ceramide when exposed to cigarette smoke extract (Thatcher et
al., 2014). Following the previously explained positioning of the lungs to the cardiovascular
4

system and by extension the rest of the body through the blood supply, we hypothesized that
skeletal muscle would be affected by cigarette smoking either through the secreted ceramides or
the dangerous metabolic cocktail of cigarette smoke. We were able to demonstrate that cigarette
smoke exposure leads to an increased accumulation of ceramide in skeletal muscle (Thatcher et
al., 2014).
This finding goes well with other previous discoveries in our lab regarding ceramide and
mitochondrial function. The word mitochondria gives a clue as to how mitochondria are. Mitos
means thread and chondria refers to a network. The mitochondria are a reticular network
throughout the cell (Ishihara, Jofuku, Eura, & Mihara, 2003). A healthy mitochondria is a part of
this network, or mitochondrion, while an unhealthy state of mitochondria involves fission that
reduces the size of the reticular network. We found that ceramides stimulate mitochondrial
fission via dynamin related protein 1 leading to reduced mitochondrial respiration and oxidative
stress (Smith et al., 2013).
These discoveries, along with other research performed in our lab and by others, led us to
investigate what happens to the heart in challenging conditions. The heart is a tissue highly
reliant upon mitochondria (Lopaschuk & Jaswal, 2010) and perhaps the most important organ in
the body. To the best of our knowledge, the study described in the following chapter is the first
investigation into the interaction of the heart and cigarette smoke using ceramide as a potential
mediator for disrupted mitochondrial respiration. In the study that follows, we aimed to identify
the key by which cigarette smoke induces mitochondrial deficiencies in the heart.
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Abstract
Background
Cigarette smoking is a common and lethal worldwide habit, with considerable mortality
stemming from its deleterious effects on heart function. While current theories posit altered
blood lipids and fibrinogen metabolism as likely mediators, none have explored the role of the
sphingolipid ceramide in exacerbating heart function with smoke exposure. Ceramide production
is a consequence of cigarette smoke in the lung, and considering ceramide’s harmful effects on
mitochondrial function, we sought to elucidate the role of ceramide in mediating smoke-induced
altered heart mitochondrial respiration.
Methods
Lung cells (A549) were exposed to cigarette smoke extract (CSE) and heart cells (H9C2)
were exposed to the lung-cell conditioned medium. Adult male mice were exposed sidestream
cigarette smoke for 8 weeks with dietary intervention and ceramide inhibition. Ceramides and
heart cell or myocardial mitochondrial respiration were determined.
Results
Lung cell cultures revealed a robust response to cigarette smoke extract in both
production and secretion of ceramides. Heart cells incubated with lung-cell conditioned medium
revealed a pronounced inhibition of myocardial mitochondrial respiration, though this effect was
mitigated with ceramide inhibition via myriocin. In vivo, heart ceramides increased roughly
600% in adult mice with long-term side stream cigarette smoke exposure. This resulted in a
significant ceramide-dependent reduction in left myocardial mitochondrial respiration, as heart
mitochondria from the mice exposed to both smoke and myriocin injections respired normally.
11

Conclusions
These results suggest ceramide to be an important mediator of altered myocardial
mitochondrial function with cigarette smoke exposure. Thus, anti-ceramide therapies might be
considered in the future to protect heart mitochondrial function with smoke exposure.
Background
Cigarette smoke exposure is the leading cause of preventable deaths worldwide (WHO,
2011) and is among the top ten contributors to the worldwide health burden (Deitel, 2003).
Despite concerted social efforts to reduce smoking prevalence, current trends suggest the number
of smokers will increase worldwide (Ng et al., 2014; SAMHS, 2011). Moreover, cigarette smoke
is a common inhaled toxin—almost half of the U.S. population is regularly exposed to cigarette
smoke (Pirkle, Bernert, Caudill, Sosnoff, & Pechacek, 2006; Pirkle et al., 1996) and
approximately 20% of young children live with someone who smokes in the home (CDC, 2010).
Much of smoking’s health burden stems from the increased risk of chronic diseases like cancer,
emphysema, and cardiovascular disease (CDC, 2008; Lakier, 1992), including
cardiomyopathy—a deterioration of heart muscle.
Cardiomyocytes are highly oxidative cells with a tremendous reliance on mitochondrial
capacity (Lopaschuk & Jaswal, 2010), and altered mitochondrial function can lead to heart
failure (Holmgren et al., 2003; Lesnefsky, Moghaddas, Tandler, Kerner, & Hoppel, 2001; Winter
& Buist, 2000), a common consequence of cardiomyopathy. Considering the importance of
healthy mitochondrial function in cardiomyocyte homeostasis, a valuable area of study is to
elucidate the factors that mediate altered heart mitochondrial physiology and its effects with
cigarette smoke exposure. Previous studies have observed that cigarette smoke exposure inhibits

12

mitochondrial respiratory function in blood cells (Miro et al., 1999) and myocardium (KnightLozano et al., 2002), but a mediating mechanism has yet to be identified.
Cigarette smoke has long been known to robustly activate inflammatory pathways in the lung
(Reynolds et al., 2010), which increases ceramide biosynthesis (Bikman, 2012; Holland et al.,
2011). Importantly, ceramides are known to disrupt mitochondrial structure and
function (Bikman & Summers, 2011; Gudz, Tserng, & Hoppel, 1997), possibly increasing risk of
cardiomyopathy (Marin-Garcia, Goldenthal, Pierpont, & Ananthakrishnan, 1995). Thus, the
purpose of these studies was to determine whether the sphingolipid ceramide mediates
cardiomyocyte mitochondrial disruption with cigarette smoke exposure. Considering the lung’s
apposition with the environment, the lung is a logical site of external pathogen-induced stress, a
product of which is ceramide biosynthesis (Holland et al., 2011). Moreover, given the heart’s
location relative to pulmonary blood flow, the heart is a reasonable site of lung-derived ceramide
uptake.
Methods
Cell Culture
Cigarette smoke extract (CSE) was generated as previously described with slight
modifications (Reynolds, Cosio, & Hoidal, 2006). Briefly, one 2RF4 research cigarette
(University of Kentucky, Lexington, KY) was continuously smoked by connecting the filtered
end of the cigarette to a vacuum pump, pulling the particles into 5 ml of DMEM/F12 and the
resulting medium was defined as 100% CSE. The total particulate matter content of 2RF4
cigarettes is 11.7 mg/cigarette, tar is 9.7 mg/cigarette, and nicotine is 0.85 mg/cigarette.
Dilutions were made using DMEM/F12 + 10% FBS. Human type II–like pulmonary
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adenocarcinoma cells (A-549; passage 10-15) were maintained in DMEM/F12 supplemented
with 10% FBS (Invitrogen) and antibiotics. Cells were split into 6-well dishes and grown to 80%
confluence. H9C2 cardiomyocytes were maintained in DMEM +10% FBS. For differentiation
into myotubes, cells were grown to confluency and the medium was replaced with DMEM +10%
horse serum (Invitrogen, Grand Island, NY). Myotubes were used for experiments on day 3 of
differentiation. A-549 cultures were exposed to media supplemented with 10% CSE or media
alone for 4 h, after which the medium was transferred to differentiated H9C2 cardiomyocytes
(termed “conditioned medium”) for 12 h. Where indicated, cells were treated with myriocin
(10 μM, Sigma, M1177), a known and widely used inhibitor of ceramide biosynthesis. Muscle
cells were harvested for RNA, protein, and lipid isolation following treatments. Cell survival
during treatments was confirmed by trypan blue exclusion.
Animals
Male C57Bl6 mice were housed in a conventional animal house and maintained on a 12hour light–dark cycle. Two animal studies were conducted. In the first study, animals received
standard diet chow (Harlan Teklad 8604) and water ad libitum. At 12 wk of age, animals were
randomly divided into room air and cigarette smoke (CS)-exposed groups. Mice were placed in
soft restraints and connected to the exposure tower of a nose-only exposure system (InExpose
System, Scireq, Canada). Animals were nasally exposed to sidestream CS generated by research
cigarettes where a computer-controlled puff was generated every minute, leading to 10 min of
CS exposure followed by 10 min of fresh air, repeated once. The CS-exposed group inhaled CS
from two cigarettes per day for one week, at which point the dosage was increased to two
cigarettes twice daily. Control animals were similarly handled and restrained in fresh air for the
same duration. For the second study, 12-wk-old mice were separated into one of eight treatment
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groups for eight weeks. Each of the following groups were duplicated to have one group receive
vehicle or myriocin injections (0.3 mg/kg) every other day for a total of eight groups: 1) control
– standard diet chow, no smoke; 2) cigarette smoke exposure (two cigarettes, twice daily) with
standard diet chow; 3) high-fat, high-sugar diet (Harlan Teklad 45F30S); 4) high-fat, high-sugar
diet with cigarette smoke exposure. Tissues were harvested at the conclusion of the study period.
Studies were conducted in accordance with the principles and procedures outlined in the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee (IACUC) at Brigham Young
University.
Lipid Analysis
For isolation of lipids, cell pellets or tissue were suspended in 900 μl ice-cold
chloroform/methanol (1:2) and incubated for 15 minutes on ice, then briefly vortexed. Separation
of aqueous and organic phases required addition of 400 μl of ice-cold water and 300 μl of icecold chloroform. The organic phase was collected into a fresh vial, and lipids were dried in a
vacuum centrifuge (Eppendorf Concentrator Plus). Lipids were characterized and quantified
using a shotgun lipidomics technique on a Thermo Scientific LTQ Orbitrap XL mass
spectrometer. Evaporated lipid samples were re-suspended in a 2:1 chloroform: methanol Folch
solution (200 μL). The re-suspended lipids were then combined with a modified 2:1:1.25
chloroform: methanol: isopropanol Bligh and Dyer solution (800 μL) with 15 mM ammonium
acetate acting as an ionizing adduct. A 1.74 μM phosphatidylethanolamine, 1 μM C-17 ceramide,
1 μM tripalmitin internal standard cocktail (1 μL) was spiked into each sample for mass
calibration and characterization data alignment. Samples were analyzed using a 2.5-minute masswindow scanning method in positive-ion mode at a resolution of 100,000 (FWHM at 400 m/z)
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for all primary MS1 scans. MS2 fragmentation data was also collected (PQD at relative intensity
of 35) and manually verified for each mass window to give additional confidence to the correct
identification of abundant lipid species. Three technical replicate mass spectrometer runs were
performed on each sample. Samples were injected at 8 μL/min using a direct-inject electrospray
ionization (ESI) soft-ionization spray head from a Hamilton GASTIGHT glass syringe. A
nitrogen sheath gas spray flow rate of 8 (arb. Units) was used for all runs. The spray voltage and
capillary temperature were maintained at 5.0 KV and 275°C respectively. Each technical
replicate was run in random order to reduce systematic bias. Data were analyzed using in-house
developed peak summarization, recalibration, and lipid identification software using lipid
database information from the LIPID Metabolites and Pathways Strategy (Lipid MAPS)
Lipidomics Gateway database (Fahy et al., 2009). To ensure high-confidence identifications, an
intensity threshold estimated to be 5% above instrumental static signal was implemented. Lipid
identities were only assigned when significantly observable peaks were identified in at least two
of the three technical replicate runs. Non-zero lipid quantities were averaged from the replicate
runs. The lipid species identified across different ionization states or with adducts were totaled
together. Quantification was completed by normalizing total ion counts to the relative abundance
of the internal standard that was spiked into each sample.
Cell and Myocardium Permeabilization
For cells, H9C2 cardiomyocytes were detached in culture dishes with 0.05% trypsinEDTA (Sigma) and growth medium was added to the culture. Contents were transferred to a tube
and centrifuged for 10 min at 1000 × g at RT. After removal of supernatant, cells were lifted in
MiR05 [0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4,
20 mM HEPES, 110 mM sucrose, and g/l BSA (Sigma; A3803) adjusted to pH 7.1] plus 1 mg/ml
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digitonin and gently rocked at RT for 5 min before centrifugation at 1000 × g for 5 min. After
discarding supernatant, cells were then suspended in 2.2 ml warm MiR05 and transferred to
chambers in the O2K (Oroboros Instruments, Innsbruck, Austria). Following respiration protocol
(outlined below), cells were removed from the chambers and used for further analysis, including
protein quantification. For myocardial mitochondrial respiration, left ventricle was quickly
removed from euthanized mice and immediately placed in ice-cold buffer X (60 mM K-MES,
35 mM KCl, 7.23 mM K2EGTA, 2.77 mM CaK2EGTA, 20 mM imidazole, 20 mM tuarine,
5.7 mM ATP, 15 mM PCr, 6.56 mM MgCl2-6H2O, pH 7.1) and trimmed of connective tissue.
Small fiber bundles were prepared and gently separated along their longitudinal axis under a
surgical scope (Olympus, ST) to 1-2 mg. Bundles were then transferred to a tube with chilled
buffer X and 50 μg/ml saponin and rocked at 4°C for 30 min, then washed in buffer Z
(105 mM K-MES, 30 mM KCl, 10 mM KH2PO4, 5 mM MgCl2-6H2O, 0.5 mg/ml BSA, pH 7.1)
at 4°C for at least 15 min. Samples were then blotted dry and weighed.
Mitochondrial Isolation
To isolate mitochondria from left ventricle myocardium, the whole heart was placed in
isolation buffer (300 mM sucrose, 10 mM Na-HEPES, 0.2 mM EDTA, pH 7.2) and the left
ventricle isolated. After finely mincing the sample, trypsin (Sigma T9935) was added for two
minutes before adding trypsin inhibitor (Sigma T9003). The sample was then transferred to a
conical tube and allowed to settle. After removal of supernatant, samples were resuspended in
isolation buffer with BSA (Sigma A3803) and homogenized with Teflon pestle before
centrifugation (600 × g for 10 min at 4°C). Supernatant was then transferred to a new tube and
centrifuged (8000 × g for 15 min at 4°C), then washed by gently adding isolation buffer and
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rotating the tube. A portion of this suspension is used for protein quantification. The pellet was
then resuspended with isolation buffer + BSA.
Mitochondrial Respiration Protocol
High-resolution O2 consumption was determined at 37°C in permeabilized cells and fiber
bundles using the Oroboros O2K Oxygraph with MiR05 respiration buffer. Before addition of
sample into respiration chambers, a baseline respiration rate was determined. After addition of
sample, the chambers were hyperoxygenated to ~350 nmol/ml. Following this, respiration was
determined by all or parts of the following substrate-uncoupler-inhibitor-titration (SUIT)
protocol (Smith et al., 2013): electron flow through complex I was supported by
glutamate + malate (10 and 2 mM, respectively) to determine basal oxygen consumption (GMB).
Following stabilization, ADP (2.5 mM) was added to determine oxidative phosphorylation
capacity (GMP). Succinate was added (GMSP) for complex I + II electron flow into the Qjunction. To determine full electron transport system (F) capacity over oxidative
phosphorylation, the chemical uncoupler carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP) was added (0.05 μM, followed by 0.025 μM steps until maximal
O2 flux was reached). Complex II-supported ETS was then measured by inhibiting complex I
with rotenone (Rot; 0.5 μM). Mitochondrial membrane integrity was tested in all experiments by
adding cytochrome c (10 μM; GMcP). Lastly, residual oxygen consumption was measured by
adding antimycin A (2.5 μM) to block complex III action, effectively stopping any electron flow,
which provides a baseline rate of respiration. Where indicated, C2-ceramide (Sigma A7191;
20 μM) was added to respiration chambers.
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Statistics
Data are presented as the mean ± SEM. Data were compared by ANOVA with Tukey’s
post-hoc analysis (Graphpad Prism; La Jolla, CA). Significance was set at p <0.05.
Results
Ceramide Inhibits Cardiomyocyte Mitochondrial Respiration
To determine the effects of ceramide on cardiac mitochondrial respiration, we utilized
two models. First, mitochondria were isolated from left ventricle myocardium. During the course
of the respiration protocol in the isolated mitochondria, C2-ceramide was added to one oxygraph
chamber. The addition of ceramide (+C2) elicited a rapid and significant reduction in
mitochondrial respiration that was sustained through maximal respiration with FCCP (Figure 2.1
A; see Methods for protocol details). A second model was the use of permeabilized intact left
ventricle myocardium. One sample was incubated with C2-ceramide throughout the length of the
protocol, which elicited a sustained reduction in mitochondrial respiration throughout the entire
protocol (Figure 2.1 B).
Cigarette Smoke Extract Increases Lung Cell Ceramide Production and Secretion
The deleterious effect of cigarette smoking on heart function is undeniable, but the
mechanism communicating the pulmonary insult to the heart is not clear. As proof of concept
that the lung is capable of producing and secreting ceramides with smoke exposure, we treated
A549 alveolar type 2 cells with cigarette smoke extract (CSE). Relative to PBS treatment,
ceramides increased over 60% in CSE-treated lung cells, though this effect was mitigated with
myriocin co-treatment (Figure 2.2 A). Further, CSE treatment elicited an almost three-fold
increase in ceramide secretion into medium compared with PBS treatment (Figure 2.2 B). We
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also observed an upward trend (P = 0.069) in circulating ceramides from whole blood following
5 d of sidestream smoke exposure in adult mice (Figure 2.2 C).
Ceramide is Necessary for Smoke Extract-Induced Altered Cardiomyocyte
Mitochondrial Disruption
To determine the effects of lung cell-secreted ceramides on heart cell function, we
utilized a conditioned medium in vitro model. Briefly, following incubation with PBS- or CSEcontaining medium, with or without myriocin co-treatment, the conditioned medium from lung
cells was transferred to H9C2 cardiomyotubes for 12 h. Following the incubation with
conditioned medium, we determined cardiomyotube ceramide accrual and mitochondrial
respiration. Ceramides were significantly increased in cardiomyotubes treated with conditioned
medium from CSE-treated lung cells (Figure 2.3 A). However, when lung cells received
treatment with myriocin in addition to CSE, the conditioned medium had no effect on heart cell
ceramides (Figure 2.3 A). Mitochondrial respiration in the heart cells followed a similar trend as
ceramides. Namely, respiration in heart cells receiving CSE conditioned medium was negatively
affected, but not when myriocin was included in the lung cell culture medium (Figure 2.3 B).
Ceramide Inhibition Prevents Reduced Myocardial Mitochondrial Respiration with
Cigarette Smoke
To more accurately determine the role of ceramides in mediating smoke-induced decayed
heart mitochondrial respiration, we exposed animals to CS for 1 wk while receiving injections of
PBS (vehicle) or myriocin every other day. Left ventricle ceramides increased four fold with CS
compared with room air-exposed mice (Figure 2.4 A) with vehicle injections, though myriocin
prevented this effect. Moreover, respiration was protected from CS in myriocin-injected animals
(Figure 2.4 B).
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Given the evidence suggesting the role of diet in increasing heart complications (Wilson,
Tran, Salazar, Young, & Taegtmeyer, 2007) and ceramide accrual (Baranowski, Blachnio,
Zabielski, & Gorski, 2007), we provided a high-fat, high-sugar (Western diet; WD) to animals in
conjunction with smoke (or room air) exposure over the course of an 8-wk study. Similar to
before, animals received vehicle (PBS) or myriocin injections every other day. In addition to
observing a roughly 6-fold increase in heart ceramides with smoke exposure, we found an
equally great increase in heart ceramides in animals receiving WD diet and smoke (Figure 2.5
A). However, ceramide inhibition was only partially successful in the WD + CS group. In
general, ceramide accrual was associated with reduced myocardial mitochondrial respiration
(Figure 2.5 B).
Discussion
Previous research demonstrated that smoke exposure contributes to cardiomyopathy
(Gvozdjakova et al., 1984; Lough, 1978), which can be a consequence of altered mitochondrial
function (Marin-Garcia et al., 1995), and we have recently shown that sidestream smoke alters
mitochondrial function in skeletal muscle (Thatcher et al., 2014). Considering current worldwide
smoking trends (Ng et al., 2014; SAMHS, 2011), cardiomyopathy and other cardiovascular
burdens mediated by cigarette smoke are likely to increase. To date, the main instigators thought
to mediate the heart-specific effects of smoking are altered blood lipids and changes in
fibrinogen metabolism, (Cullen, Schulte, & Assmann, 1998; Newby et al., 1999), though the
actual impact of these mechanisms is unknown (Cullen et al., 1998). While ceramides are known
to mediate cellular disruption in the lung with smoking (Petrache et al., 2005), its impact on
cardiomyocyte function with smoking has not been adequately explored. Thus, the purpose of
this project was to determine the role of tobacco smoke-induced ceramides in disrupting
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cardiomyocyte mitochondrial function. Our major discoveries were that lung cells secrete
ceramide with sidestream smoke exposure and that ceramide accumulates in heart tissue and
alters mitochondrial function.
To our knowledge, the first study to explore the effects of ceramide on mitochondrial
respiration was published by the Hoppel laboratory, where they observed a rapid and robust
inhibition of respiration in isolated heart mitochondria upon ceramide treatment (Gudz et al.,
1997), and subsequent work corroborates these findings (Novgorodov & Gudz, 2009). We
confirm those observations by Gudz et al. (Gudz et al., 1997) in isolated heart mitochondria and
report similar findings in permeabilized left ventricle. Additionally, we have previously shown
that ceramides substantially inhibit complex II action and that the general adverse effect of
ceramides on mitochondrial respiration is dependent on ceramide-induced mitochondrial fission
(Smith et al., 2013). Similarly, our findings of ceramide accrual in the lung with smoking
corroborate those from other laboratories (Filosto et al., 2011; Levy, Khan, Careaga, &
Goldkorn, 2009; Schweitzer et al., 2011), but while previous work focused on ceramide
generation via sphingomyelinase, our effective use of myriocin suggests the importance of de
novo ceramide synthesis in sidestream smoke-induced ceramide accumulation. However, while
myriocin injections were sufficient to completely block ceramide accrual with smoking or diet
separately, it was insufficient to prevent an increase in ceramides with combined smoking and
diet. This may be a result of insufficient myriocin action in the midst of an overpowering
stimulus (diet and smoke combined), or that sphingomyelinase may be particularly relevant in
our combined treatment.
Importantly, we not only find increased ceramide production in lung cells with smoke
exposure, but also ceramide release, providing proof of concept that the lung may be at least a
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source of systemic ceramide accrual with smoke exposure. This is supported by our finding of an
upward trend in circulating ceramides with smoke exposure. Nonetheless, ongoing experiments
are testing the hypothesis that secreted ceramide by smoke-exposed pulmonary tissues travel and
accumulate in cardiac muscle. Related to this, our conclusions that ceramide is the relevant
component within the cultured medium upon transfer of medium from lung cells to
cardiomyocytes is based on our use of myriocin. However, due to the harmful cocktail of
molecules within the CSE, it is possible that a non-ceramide variable exists.
The level of ceramide accumulation we observe in the heart with smoking is substantial.
We have previously quantified ceramide in various tissues (i.e., skeletal muscle, liver, brain)
with dietary intervention (Bikman et al., 2012; Holland et al., 2011; Smith et al., 2013) and rarely
observed greater than a roughly twofold increase in ceramides; similar changes have been
observed in the heart (Baranowski et al., 2007). However, cigarette smoking appears to be a
more robust inducer of systemic ceramide accumulation compared with diet. We found a roughly
four-fold increase in heart ceramides after only 1 wk of smoke exposure (Figure 2.4) that
increased to a six-fold change with an 8-wk exposure (Figure 2.5 A). Interestingly,
supplementing the smoking regimen with a dietary component (Western diet, Harlan Teklad
45F30S) had no additive effect on heart ceramides (Figure 2.5 A).
Conclusions
In conjunction with our recent findings of altered skeletal muscle function with cigarette
smoke exposure (Thatcher et al., 2014), the results of these studies implicate ceramide as an
important mediator of myriad systemic metabolic effects. In particular, we find evidence that
ceramides are a mediator of sidestream smoke-induced altered heart mitochondrial function.
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While interventions to promote smoking cessation should continue, the increase in worldwide
smoking and cardiovascular complications highlights the need for immediate therapies. Our
findings suggest that ceramide inhibition may be a novel and potentially valuable therapeutic
modality to protect heart function for those who are unwilling or unable to vacate smoke
environments.
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Figure 2.1: Ceramide Inhibits Left Ventricle Mitochondrial Respiration
A: Respiration rates of mitochondria isolated from left ventricle myocardium with addition of
C2-ceramide during respiration protocol (20 μM; n = 4).
B: Mitochondrial respiration from permeabilized left ventricle myocardium (30 min) with
continuous incubation with C2-ceramide (20 μM; n = 8). See Methods for more details on
respiration protocol. *P <0.05.
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Figure 2.2: Lung Cells Make and Secrete Ceramide in Response to Cigarette Smoke Extract
A: Ceramide levels in A549 cells treated with PBS- or 10% cigarette smoke extract-containing
medium without (CSE) or CSE with myriocin (CSE + Myr), a ceramide inhibitor, for 12 h
(n = 6).
B: Ceramides in culture medium of A549 cells following a 12-h treatment with PBS or CSE
(n = 6).
C. Ceramides were determined from whole blood of adult mice following 5 d of room air (CON)
or sidestream cigarette smoke (CS) (P =0.069; n = 5). *P <0.05 for CSE vs. PBS.
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Figure 2.3: Ceramide is Necessary for Decreased Mitochondrial Respiration in Myocardial Cells
Following Treatment with Conditioned Medium from CSE-Treated Lung Cells
A: Ceramide levels in H9C2 cardiomyocytes treated with conditioned medium from A549
alveolar type 2 cells following incubation with normal growth medium (Con), Con with myriocin
(Myr), cigarette smoke extract (CSE), and CSE with Myr (CSE + Myr) (n = 4).
B: Mitochondrial respiration from H9C2 cardiomyocytes following treatment in identical
conditions (n = 5). See Methods for more details on respiration protocol. *P <0.05 for CSE vs.
Con.
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Figure 2.4: Myriocin Prevents Left Ventricle Ceramide Accrual and Mitochondrial Dysfunction
with Cigarette Smoke
Mice were exposed to room air (Con) or cigarette smoke (CS) for 1 wk while receiving PBS
(vehicle) or myriocin injections every other day.
A: Ceramides were measured from left ventricle following treatment period (n = 6).
B: Mitochondrial respiration was reduced with CS treatment in vehicle-injected animals (n = 6).
*P <0.05 for CS vs all other treatments.
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Figure 2.5: Western Diet Exerts a Minimal Effect on Heart Ceramides in Cigarette SmokeExposed Mice
Mice were exposed to room air (Con) or cigarette smoke (CS) for 8 wk while receiving PBS
(vehicle) or myriocin injections every other day. Mice also received either a standard diet (SD)
or Western diet (WD).
A: Ceramides were measured from left ventricle following treatment period (n = 4).
B: Mitochondrial respiration was determined from permeabilized left ventricle myocardium
(n = 8). *P <0.05 for treatment vs. Vehicle SD. #P <0.05 for WD + CS myriocin vs. WD + CS
vehicle.
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CHAPTER 3: General Discussion and Future Directions
The data from the previous chapter provides strong evidence that cigarette smoke is a
potent ceramide synthesis agonist in cardiomyocytes. The increased ceramide accrual in the
cardiomyocytes contributes to mitochondrial dysfunction via decreased mitochondrial respiration
and potentially mitochondrial fission as shown previously by our lab (Smith et al., 2013).
Mitochondrial function is essential for cardiomyocytes due to the highly oxidative nature of the
heart. Our work builds on the previous work done by Knight-Lozano et al. showed that cigarette
smoke leads to decreased mitochondrial respiration in myocardium (Knight-Lozano et al., 2002).
This work suggests that ceramide plays the role of a mediating mechanism of cigarette smoke
induced depression of cardiomyocyte mitochondrial respiration.
A salient point shown by the study involves ceramide and the left ventricular
myocardium. Anatomically, the left ventricle is the powerful section of the heart with the
responsibility to pump oxygenated blood to the rest of the body. Ceramide had been previously
shown by Di Paola et al. to interact with the respiratory chain of mitochondria in the heart (Di
Paola, Cocco, & Lorusso, 2000). We exposed isolated left ventricular myocardial mitochondria
to ceramide because of the previously mentioned dynamic of cigarette smoke leading to the
lungs and then directly from the lungs to the heart. We showed that ceramide added to isolated
mitochondria leads to a depressed respiration in the maximum respiration state and the remaining
states of respiration. Additionally, ceramide was shown to increase in mouse myocardium after 1
week of cigarette smoke exposure. We also performed a chronic treatment with cigarette smoke
over an 8 week period. This extended treatment showed even greater ceramide accumulation in
the left ventricular myocardium. Interestingly, when a western diet was introduced along with
cigarette smoking, we saw a trend towards an additional accumulation of ceramide occurring.
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The study presented in this thesis supports the model derived from previous work in our
lab. This data has taken our past research and shown that cigarette smoke induces mitochondrial
respiration deficiencies via ceramide. Additional work to fully elucidate the mechanisms and
other factors involved with ceramide and mitochondrial respiration should be completed and will
prove to be a novel area of research.
In line with our previous work, our data showed that ceramide was a necessary
component for a significant reduction in left ventricular mitochondrial respiration. Using
myriocin, a ceramide synthesis inhibitor, we were able to protect the heart against the effects of
increased ceramides due to cigarette smoke exposure. Our success in protecting the tissue against
ceramide accrual with myriocin suggests that de novo synthesis of ceramides is the key pathway
used to produce ceramide in the study conditions. Further investigation into the importance of
the various pathways of ceramide production may prove to be a key point of interest in finding
therapeutic treatments for cigarette smoke induced cardiac mitochondrial complications.
The western diet slightly contributed towards increased levels of ceramide in the heart.
Interestingly, we found that myriocin treatments were able to protect against ceramide accrual in
the cigarette smoke and the western diet treatments when the two treatments were mutually
exclusive. However, when the western diet and cigarette smoke treatments were combined, a
significant accumulation of ceramides, compared to the myriocin control, cigarette smoke, and
western diet groups occurred. This finding opens an area of further study. Our results from the
mutually exclusive testing of cigarette smoke and western diet suggest that the de novo pathway
in the synthesis of ceramide is the main contributor to ceramide accrual. Sphingomyelinase or
other sources of ceramide (excluding the de novo pathway) may be important contributors in the
combined insult of cigarette smoke exposure and the high fat-high sugar western diet.
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Knowing that particulate insults such as cigarette smoke increase ceramide production in
both the lung, heart, and other tissues, other avenues for research are appealing. With BYU
residing in the Wasatch Front of Utah, an area consistently criticized for air pollution, exploring
the effects of inversions and pollution on the heart would be a natural next step. Air pollution has
long concerned the scientific community due to its effects on the heart, inflammation and other
body systems (Brook et al., 2004). Air pollution has been shown to be associated with
perturbations of heart rate and inflammatory responses (C. A. Pope, 3rd et al., 2006; C. A. Pope
et al., 2004). Further investigation as to whether or not ceramide plays a role in these observed
effects is warranted.
In conclusion, cigarette smoke up-regulates the production of ceramide in the heart. The
enzymes that appear to be the major contributors to the extra synthesis of ceramide are the
enzymes involved in the de novo synthesis pathway. The combined high fat-high sugar western
diet and cigarette smoke treatment is able to overcome the myriocin inhibition of ceramide
production in one of two ways. Either the ceramide accrual occurred through incomplete
inhibition of the de novo pathway or a different pathway is contributing to ceramide production.
The data presented in this thesis provides evidence that anti-ceramide treatments may be a
unique, novel target for the prevention of cardiomyopathy or other pathologies of cardiac stress
due to reduced mitochondrial function. At minimum, anti-ceramide treatments may be able to
protect cardiac mitochondrial function where cigarette smoke exposure is occurring.
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